Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu; Wei Chun HuangFu; Han Li Huang; Wei Cheng Wu; Yi Lin Chen; Yun Yen; Hsiang Ling Huang; Chih Ying Nien; Mei Jung Lai; Shiow Lin Pan; Jing Ping Liou

doi:10.1016/j.ejmech.2020.112633

Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

Yi Min Liu
, Wei Chun HuangFu
, Han Li Huang
, Wei Cheng Wu
, Yi Lin Chen
, Yun Yen
, Hsiang Ling Huang
, Chih Ying Nien
, Mei Jung Lai
, Shiow Lin Pan
, Jing Ping Liou

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

2 引文斯高帕斯（Scopus）

摘要

The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

原文	英語
文章編號	112633
期刊	European Journal of Medicinal Chemistry
卷	202
DOIs	https://doi.org/10.1016/j.ejmech.2020.112633
出版狀態	已發佈 - 9月 15 2020

ASJC Scopus subject areas

藥理
藥物發現
有機化學

存取文件

10.1016/j.ejmech.2020.112633

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)」主題。共同形成了獨特的指紋。

引用此

Liu, Y. M., HuangFu, W. C., Huang, H. L., Wu, W. C., Chen, Y. L., Yen, Y., Huang, H. L., Nien, C. Y., Lai, M. J., Pan, S. L., & Liou, J. P. (2020). Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). European Journal of Medicinal Chemistry, 202, 文章 112633. https://doi.org/10.1016/j.ejmech.2020.112633

Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). / Liu, Yi Min ; HuangFu, Wei Chun; Huang, Han Li 等.
於: European Journal of Medicinal Chemistry, 卷 202, 112633, 15.09.2020.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Liu, YM , HuangFu, WC, Huang, HL, Wu, WC, Chen, YL, Yen, Y, Huang, HL, Nien, CY, Lai, MJ , Pan, SL & Liou, JP 2020, 'Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)', European Journal of Medicinal Chemistry, 卷 202, 112633. https://doi.org/10.1016/j.ejmech.2020.112633

Liu YM , HuangFu WC, Huang HL, Wu WC, Chen YL, Yen Y 等. Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011). European Journal of Medicinal Chemistry. 2020 9月 15;202:112633. doi: 10.1016/j.ejmech.2020.112633

@article{e64f9af6878947cdaafc6b7c9adff590,

title = "Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)",

abstract = "The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.",

author = "Liu, \{Yi Min\} and HuangFu, \{Wei Chun\} and Huang, \{Han Li\} and Wu, \{Wei Cheng\} and Chen, \{Yi Lin\} and Yun Yen and Huang, \{Hsiang Ling\} and Nien, \{Chih Ying\} and Lai, \{Mei Jung\} and Pan, \{Shiow Lin\} and Liou, \{Jing Ping\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Masson SAS",

year = "2020",

month = sep,

day = "15",

doi = "10.1016/j.ejmech.2020.112633",

language = "English",

volume = "202",

journal = "European Journal of Medicinal Chemistry",

issn = "0223-5234",

publisher = "Elsevier Masson s.r.l.",

}

TY - JOUR

T1 - Corrigendum to “1,4-Naphthoquinones as inhibitors of Itch, a HECT domain-E3 ligase, and tumor growth suppressors in multiple myeloma” [Eur. J. Med. Chem. 140 (2017) 84–91](S0223523417306931)(10.1016/j.ejmech.2017.09.011)

AU - Liu, Yi Min

AU - HuangFu, Wei Chun

AU - Huang, Han Li

AU - Wu, Wei Cheng

AU - Chen, Yi Lin

AU - Yen, Yun

AU - Huang, Hsiang Ling

AU - Nien, Chih Ying

AU - Lai, Mei Jung

AU - Pan, Shiow Lin

AU - Liou, Jing Ping

PY - 2020/9/15

Y1 - 2020/9/15

N2 - The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the information of concentration unit of the Table 2 and 3 and the name of synthesized compound 10e in 4.1.1.5 was incorrect. The correct version should be: The concentration unit of the Table 2 and 3 is μM. The name of synthesized compound 10e is 4-(((3-Chloro-1,4-dioxo-1,4-dihydronaphthalen-2-yl)amino)methyl)-N-(pyridin-4-yl)benzamide (10e) in 4.1.1.5. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/85088017535

UR - https://www.scopus.com/pages/publications/85088017535#tab=citedBy

U2 - 10.1016/j.ejmech.2020.112633

DO - 10.1016/j.ejmech.2020.112633

M3 - Comment/debate

C2 - 32688164

AN - SCOPUS:85088017535

SN - 0223-5234

VL - 202

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

M1 - 112633

ER -